carnitine has been researched along with simvastatin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellinghieri, G; Lamanna, F; Savica, V | 1 |
| Hsieh, ST; Ishikawa, Y; Kim, JI; Miki, T; Tanaka, S; Taniguchi, T; Yasumoto, T; Yokoyama, M | 1 |
| Arduini, A; Carminati, P; Giannessi, F; Peschechera, A | 1 |
| Capurso, A; Capurso, C; Capurso, SA; Colacicco, AM; D'Introno, A; Fontana, C; Gadaleta, AM; Koverech, A; Panza, F; Solfrizzi, V; Torres, F | 1 |
| Galvano, F; Li Volti, G; Malaguarnera, M; Motta, M; Vacante, M | 1 |
| Antic, T; Avitabile, T; Galvano, F; Li Volti, G; Malaguarnera, M; Vacante, M | 1 |
| Costa, RA; de Souza-Pinto, NC; Fernandes, MP; Vercesi, AE | 1 |
| Bilianou, E; Elisaf, MS; Florentin, M; Liberopoulos, EN; Nikolaou, V; Pitsavos, C; Rizos, CV | 1 |
| El-Adeeb, N; Elmasry, A; Ghalwash, M | 1 |
| Antunes, NJ; Campos, R; De Nucci, G; Dezena, RMB; Ilha, J; Mendes, GD; Moreno, RA; Rosa, PCP | 1 |
| Badreldeen, A; El Amrousy, D; El Razaky, O; El-Bendary, A; Erfan, A | 1 |
| Abraldes, JG; Alessandria, C; Beuers, U; Campion, D; Caraceni, P; Carol, M; Davis, MM; de Wit, K; Durand, F; Francoz, C; Ginès, P; Jiménez, C; Juanola, A; Kamath, PS; Kazankov, K; Lozano, JJ; Ma, AT; Mookerjee, RP; Morales-Ruiz, M; Napoleone, L; Piano, S; Pose, E; Sidorova, J; Solà, E; Tonon, M; Trebicka, J; Uschner, F; Vargas, V; Watson, H; Zaccherini, G | 1 |
| Abd El Reheem, MH; Ahmed, SA; Elbahy, DA | 1 |
6 trial(s) available for carnitine and simvastatin
| Article | Year |
|---|---|
Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Topics: Aged; Apolipoproteins B; Carnitine; Cholesterol; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Italy; Lipoprotein(a); Male; Middle Aged; Simvastatin; Triglycerides | 2006 |
Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin.
Topics: Adult; Aged; Blood Glucose; Carnitine; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Simvastatin | 2009 |
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus.
Topics: Apoprotein(a); Blood Glucose; Body Mass Index; Carnitine; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Simvastatin; Triglycerides | 2009 |
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
Topics: Adult; Apolipoprotein B-100; Cardiovascular Diseases; Carnitine; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type V; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides; Young Adult | 2017 |
Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial.
Topics: Captopril; Carnitine; Carotid Intima-Media Thickness; Child; Diabetes Mellitus, Type 1; Humans; Pharmaceutical Preparations; Simvastatin | 2021 |
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
Topics: Acute-On-Chronic Liver Failure; Carnitine; Humans; Kynurenine; Liver Cirrhosis; Metabolomics; Rifaximin; Simvastatin; Tryptophan | 2022 |
11 other study(ies) available for carnitine and simvastatin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[The hypotriglyceridemic action of the combination of L-carnitine + simvastatin vs. L-carnitine and vs. simvastatin].
Topics: Aged; Anticholesteremic Agents; Carnitine; Combined Modality Therapy; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertriglyceridemia; Kidney Failure, Chronic; Lovastatin; Male; Middle Aged; Renal Dialysis; Simvastatin | 1992 |
A case of severe hyperlipidemia caused by long-term tube feedings.
Topics: Aged; Carnitine; Dietary Sucrose; Enteral Nutrition; Female; Food, Formulated; Humans; Hyperlipidemias; Hypolipidemic Agents; Rhabdomyolysis; Simvastatin | 2003 |
Improvement of statin-associated myotoxicity by L-carnitine.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carnitine; Cell Membrane; Cholesterol; Creatine Kinase; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscles; Rats; Rats, Wistar; Simvastatin | 2004 |
Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin.
Topics: Carnitine; Cell Line, Tumor; Cyclosporine; Drug Synergism; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Piracetam; Simvastatin; Superoxides | 2013 |
Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats.
Topics: Animals; Carnitine; Cholesterol; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Contraction; Muscle, Skeletal; Muscular Diseases; Oxidative Stress; Rats; Rats, Wistar; Simvastatin | 2018 |
Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Humans; Male; Piracetam; Simvastatin | 2020 |
l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Carnitine; Chemical and Drug Induced Liver Injury; Glucocorticoids; Myotoxicity; Osteoporosis; Rats; Rats, Wistar; Simvastatin | 2022 |